PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
12.50%
Some net income increase while GNPX is negative at -57.22%. John Neff would see a short-term edge over the struggling competitor.
-31.48%
Negative yoy D&A while GNPX is 35.34%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-66.70%
Negative yoy deferred tax while GNPX stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
10.78%
Less SBC growth vs. GNPX's 175.54%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-179.22%
Both reduce yoy usage, with GNPX at -1.98%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-302.85%
Negative yoy AP while GNPX is 134.86%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-91.10%
Negative yoy usage while GNPX is 9.80%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
10.78%
Lower 'other non-cash' growth vs. GNPX's 134.86%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-32.84%
Both yoy CFO lines are negative, with GNPX at -3.46%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-1.01%
Negative yoy CapEx while GNPX is 16.20%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1225.23%
We reduce yoy other investing while GNPX is 20.32%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-1611.06%
We reduce yoy invests while GNPX stands at 16.20%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-0.50%
Negative yoy issuance while GNPX is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.